Micro Emerging Active

ImmunityBio's ANKTIVA approved in Macau

新的叙述，覆盖范围有限 — 仍在形成中。

评分

0.2

动能

▲ 0.0

文章

来源

股票代码	板块	变动
BCG	Financial Services	-17.2%
IBRX	Healthcare	+5.3%

情绪时间线

四月 13, 2026

ImmunityBio, Inc. (IBRX) Posts Strong Preliminary Q1 Sales on ANKTIVA Momentum Bullish

四月 02, 2026

ImmunityBio (IBRX) Rallies 15% as Firm Raises $100M For Global Expansion Bullish

三月 25, 2026

ImmunityBio Inc. (IBRX) Announces Approval for ANKTIVA® in Macau SAR, China Neutral

股票代码	板块	变动
BCG	Financial Services	-17.2%
IBRX	Healthcare	+5.3%

首次发现三月 25, 2026

最后更新三月 25, 2026